ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1311

Prevalence of Symptomatic Axial Osteoarthritis and Poliarticular Phenotypes in Spain: EPISER 2016 Study

Maite Silva-Díaz1, Francisco J. Blanco 2, Victor Quevedo Vila 3, Daniel Seoane-Mato 4, Sagrario Bustabad-Reyes 5 and on behalf of the Working Group Proyecto EPISER2016 6, 1Servicio de Reumatología. Complexo Hospitalario Universitario A Coruña (CHUAC)-INIBIC, A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 3Unidad de Reumatología. Hospital Comarcal Monforte de Lemos., Lugo, Spain, 4Unidad de Investigación. Sociedad Española de Reumatología., Madrid, Spain, 5eumatología. Hospital Universitario de Canarias., La Laguna, Santa Cruz de Tenerife, Spain, 6Grupo de trabajo del proyecto EPISER2016, Madrid, Spain

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Osteoarthritis, phenotypes and population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose:

Osteoarthritis (OA) is a heterogeneous group of diseases with common clinical and radiographic manifestations involving the peripheral and axial skeletal. OA is the most prevalent rheumatic disease. There are very few publications focused in axial OA. In 2016, the Spanish Society of Rheumatology (SER) started a population descriptive study (EPISER 2016) to analyze the prevalence of 13 rheumatic diseases in Spain, including peripheral (hip, knee and hand) and axial (cervical and lumbar spine) OA.

OBJECTIVES: To estimate in adult population the prevalence in Spain of symptomatic OA of hand, knee, hip, cervical and lumbar spine and associated factors.

Methods:

EPISER 2016 study is a cross-sectional, population-based descriptive study. To estimate the symptomatic OA prevalence, adult population aged 40 or older was selected. The initial recruitment was made through by a call center. In a second phase rheumatologists confirmed the diagnosis. Diagnostic criteria to confirm new diagnosis of peripheral OA were ACR criteria of hand, knee and hip. The axial OA diagnostic criteria to confirm new diagnosis were both clinical and radiographic. Clinical criteria: mechanical pain longer than 3 months of evolution and stiffness of less than 30 minutes or absence of it; and radiographic criteria: vertebral osteophytes or reduction of intervertebral space with sclerosis of vertebral plate and sclerosis in interapofisary joints. To confirm the diagnosis, it was necessary that both clinical criteria and at least one radiographic criterion were met.

Results:

The sample of the EPISER study was 3,336 subjects ≥ 40, of whom 978 had peripheral or axial OA. The mean age was 64.72 years, 730 were women, 62.6% had basic education, 64,8% were overweight or obese and 83,9% were ex-smokers or non-smokers . The prevalence of global OA (peripherical+axial) was 29.35%. Prevalence of peripheral and axial OA was 19,62% and 19,17% respectively. According the prevalence of polyarticular phenotypes, the phenotype combining axial and peripheral OA was 9,66% and the phenotype combining OA in 2 or more peripherical joints (hand, knee o hip) was 5,64%.
The characteristics of patients with peripheral and axial OA follow similar patterns (Table 1).
Prevalence of cervical OA was 10.10%. In the multivariate analysis, it was observed that cervical OA is more frequent in women and older subjects, with the prevalence peak between 60-69 years. It is also more frequent in subjects with obesity and in subjects with a basic education level (Table 2 and Figure 1).
Prevalence of lumbar OA was 15.52%. Multivariate analysis also showed that lumbar OA is more frequent in women and it increases with age (prevalence peak in ≥80 years). Greater association was observed with obesity or overweight and with basic study levels. Lumbar OA prevalence was higher in population from centre of Spain compared with other areas.

Conclusion:

EPISER2016 study shows similar prevalence of peripheral and axial OA. Lumbar OA is more prevalent than cervical OA. Axial OA in Spain is more frequent in women, increases with age with a peak between 60-69 years for cervical OA and ≥ 80 years for lumbar OA. Both cervical and lumbar OA are more frequent in patients with obesity or overweight and with basic studies.


figura abstract ACR


Disclosure: M. Silva-Díaz, None; F. Blanco, None; V. Quevedo Vila, None; D. Seoane-Mato, None; S. Bustabad-Reyes, None; o. Proyecto EPISER2016, None.

To cite this abstract in AMA style:

Silva-Díaz M, Blanco F, Quevedo Vila V, Seoane-Mato D, Bustabad-Reyes S, Proyecto EPISER2016 o. Prevalence of Symptomatic Axial Osteoarthritis and Poliarticular Phenotypes in Spain: EPISER 2016 Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-symptomatic-axial-osteoarthritis-and-poliarticular-phenotypes-in-spain-episer-2016-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-symptomatic-axial-osteoarthritis-and-poliarticular-phenotypes-in-spain-episer-2016-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology